tirzepatide for ra and autoimmune disease: what the research actually shows Tirzepatide (LY3298176)

In the SURE program, this change produced an additional HbA1c-lowering effect of -0.7% and -3.7 kg of weight

This regulatory pressure has pushed some of the peptide market toward international suppliers shipping directly to Canadian consumers

The weight-loss results continued to impressive levels at the 48-week endpoint, with the 12 mg retatrutide group achieving a mean weight reduction of -24.2%, while the placebo group only saw a -2.1% change

None of the listed ingredientspeony root extract, glycerin, mineral oil, and waterhas established research showing GLP-1 receptor activation or changes in GLP-1 hormone levels

& Velasco, D